Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Dare Bioscience, Inc. (NASDAQ: DARE).

Full DD Report for DARE

You must become a subscriber to view this report.


Recent News from (NASDAQ: DARE)

Daré Bioscience, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference
SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Thursda...
Source: GlobeNewswire
Date: August, 30 2018 08:00
Premarket analyst action - healthcare
Retrophin (NASDAQ: RTRX ) initiated with Buy rating and $36 (33% upside) price target at Canaccord Genuity. More news on: Retrophin, Inc., Dare Bioscience, Inc., Esperion Therapeutics, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 17 2018 07:48
Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will present at the Canaccord Genuity 38th Annual Growth Conference on Thursday, August...
Source: GlobeNewswire
Date: August, 02 2018 08:00
Daré Bioscience, Growing Through Collaborations, Male Contraceptive, Analysts Target
NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Daré Bioscience (NASDAQ: DARE) , a clinical-stage biopharmaceutical comp...
Source: ACCESSWIRE IA
Date: July, 23 2018 08:10
Midday Gainers / Losers (07/16/2018)
Gainers: MTSL +94% . GENE +70% . CALI +65% . CODA +61% . ARC +23% . ATLC +13% . PED +13% . DARE +13% . SITO +10% . ARNC +10% . More news on: MER Telemanagement Solutions Ltd., GENETIC TECHNOLOGIES LTD, China Auto Logistics Inc., Stocks on the move, , Re...
Source: SeekingAlpha
Date: July, 16 2018 12:37
Premarket Gainers as of 9:05 am (07/16/2018)
CODA +111%   enters into a navy cooperative research and development agreement with naval surface warfare center More news on: Coda Octopus Group, Inc., GENETIC TECHNOLOGIES LTD, Tonix Pharmaceuticals Holding Corp., Stocks on the move, Read more ...
Source: SeekingAlpha
Date: July, 16 2018 09:18
Daré Bioscience to acquire contraceptive assets from Hydra Biosciences; shares up 2% premarket
Nano cap Daré Bioscience (NASDAQ: DARE ) inks an asset transfer agreement with Hydra Biosciences for all of the latter's intellectual property related to its CatSper ion channel target portfolio. More news on: Dare Bioscience, Inc., Healthcare stocks news, Stocks on the move, Re...
Source: SeekingAlpha
Date: July, 16 2018 08:17
Daré Bioscience, Inc. Announces Asset Transfer Agreement with Hydra Biosciences, Inc. for CatSper Contraceptive Target
CatSper antagonist has potential to provide pregnancy prevention via administration to either women or men as a novel, rapidly reversible, non-hormonal contraceptive SAN DIEGO, July 16, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience , Inc.  (NASDAQ:DARE), a clinical-stage, ...
Source: GlobeNewswire
Date: July, 16 2018 08:00
Free Daily Technical Summary Reports on Dermira and Three Other Biotech Stocks
Stock Research Monitor: DARE, DRNA, and EGLT LONDON, UK / ACCESSWIRE / June 18, 2018/ If you want a free Stock Review on DERM sign up now at www.wallstequities.com/registration . On Friday, the NASDAQ Composite ended the day at 7,746.38, down 0.19%; the Dow Jones Industrial Average ed...
Source: ACCESSWIRE IA
Date: June, 18 2018 07:20
Daré Bio trying to clear near-term consolidation, up 14%
Nano cap Daré Bioscience ( DARE +13.6% ) broke through the $1.50 high of a six-week base in early trade but is struggling to maintain the breakout. Shares are now exchanging hands at $1.50, down 9% from the intraday high of $1.65. More news on: Dare Bioscience, Inc., Healthcare stoc...
Source: SeekingAlpha
Date: June, 08 2018 11:13

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-081.10731.011.130.95603,800
2018-05-171.111.1611.221.07762,617

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-125,59524,57022.7717Cover
2018-12-1131,81081,89838.8410Short
2018-12-106,78526,12325.9733Cover
2018-12-0768,248168,43940.5179Short
2018-12-061,276,4202,526,44150.5225Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DARE.


About Dare Bioscience, Inc. (NASDAQ: DARE)

Logo for Dare Bioscience, Inc. (NASDAQ: DARE)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $3,106,395 - 05/15/2018
    • Issue and Outstanding: 2,903,173 - 07/20/2017

     


    Recent Filings from (NASDAQ: DARE)

    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: May, 14 2018
    Filing Type: CT ORDERFiling Source: edgar
    Filing Date: May, 08 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 04 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 30 2018
    Amendment to a previously filed 10-K
    Filing Type: 10-K/AFiling Source: edgar
    Filing Date: April, 30 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 11 2018
    Annual report with a comprehensive overview of the company
    Filing Type: 10-KFiling Source: edgar
    Filing Date: March, 28 2018
    Statement of beneficial ownership of common stock by certain persons
    Filing Type: SC 13GFiling Source: edgar
    Filing Date: February, 22 2018
    Statement of beneficial ownership of common stock by certain persons
    Filing Type: SC 13GFiling Source: edgar
    Filing Date: February, 21 2018
    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: February, 14 2018

     

     


    Daily Technical Chart for (NASDAQ: DARE)

    Daily Technical Chart for (NASDAQ: DARE)


    Stay tuned for daily updates and more on (NASDAQ: DARE)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: DARE)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DARE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of DARE and does not buy, sell, or trade any shares of DARE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/